This week, President Donald Trump signed into law a $5.9 billion spending package aimed at supporting the global response to HIV/AIDS and global public health. The signing of the appropriations bill was hailed by the Joint United Nations Programme on HIV/AIDS (UNAIDS) as providing life-saving support for millions of people across the globe.
“I thank President Trump and the US Congress for their continued commitment to HIV and global health,” UNAIDS Executive Director Winnie Byanyima, MS, said in a press release. The investment will “help to ensure that the global HIV response remains efficient, data-driven and delivers results.”
The bill allocates $4.6 billion for HIV support through the America First Global Health Strategy; $1.3 billion for the Global Fund to Fight AIDS, Tuberculosis and Malaria; and $45 million directly to UNAIDS.
Debate about US role in global health funding
US investment has been central to decades of progress in combating HIV/AIDS across the globe, according to UNAIDS, and the 2026 investment will help advance UNAIDS’ goal of ending AIDS as a public health threat by 2030. The United States has partnered with UNAIDS since its founding in 1996, and it recently renewed its membership in the UNAIDS Programme Coordinating Board through 2028.